{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:41:52Z","timestamp":1791322912391,"version":"4.3.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.vaccine.2009.04.074","type":"journal-article","created":{"date-parts":[[2009,10,18]],"date-time":"2009-10-18T08:08:20Z","timestamp":1255853300000},"page":"6276-6279","source":"Crossref","is-referenced-by-count":59,"title":["PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants"],"prefix":"10.1016","volume":"27","author":[{"given":"Takeshi","family":"Ichinohe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ainai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Tashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsutaro","family":"Sata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"August (4)","key":"10.1016\/j.vaccine.2009.04.074_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7883\/yoken.JJID.2005.195","article-title":"Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines","volume":"58","author":"Tamura","year":"2005","journal-title":"Jpn J Infect Dis"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2009.04.074_bib2","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.4049\/jimmunol.168.6.2930","article-title":"Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines","volume":"168","author":"Asahi","year":"2002","journal-title":"J Immunol"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2009.04.074_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1586\/14760584.6.2.193","article-title":"Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic","volume":"6","author":"Hasegawa","year":"2007","journal-title":"Expert Rev Vaccines"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2009.04.074_bib4","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1128\/JVI.79.5.2910-2919.2005","article-title":"Synthetic double-stranded RNA poly (I:C) combined with mucosal vaccine protects against influenza virus infection","volume":"79","author":"Ichinohe","year":"2005","journal-title":"J Virol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2009.04.074_bib5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat Immunol"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2009.04.074_bib6","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/57.3.599","article-title":"A phase I-II trial of multiple-dose polyriboinosic\u2013polyribocytidylic acid in patients with leukemia or solid tumors","volume":"57","author":"Robinson","year":"1976","journal-title":"J Natl Cancer Inst"},{"issue":"July\u2013August (4)","key":"10.1016\/j.vaccine.2009.04.074_bib7","first-page":"599","article-title":"Changes in the 2-5A synthetase\/RNase L antiviral pathway in a controlled clinical trial with poly (I)-poly (C12U) in chronic fatigue syndrome","volume":"8","author":"Suhadolnik","year":"1994","journal-title":"In Vivo (Athens, Greece)"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.04.074_bib8","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1128\/JVI.73.4.3184-3189.1999","article-title":"Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong","volume":"73","author":"Gao","year":"1999","journal-title":"J Virol"},{"issue":"April (22)","key":"10.1016\/j.vaccine.2009.04.074_bib9","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1016\/j.vaccine.2004.08.054","article-title":"Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system","volume":"23","author":"Nicolson","year":"2005","journal-title":"Vaccine"},{"issue":"Septembre (11)","key":"10.1016\/j.vaccine.2009.04.074_bib10","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.micinf.2007.06.007","article-title":"Intranasal immunization with H5N1 vaccine plus Poly I:Poly C12U, a Toll-like receptor agonist, protects mice against homologous and heterologous virus challenge","volume":"9","author":"Ichinohe","year":"2007","journal-title":"Microbes Infect\/Institut Pasteur"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2009.04.074_bib11","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1086\/521304","article-title":"Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine","volume":"196","author":"Ichinohe","year":"2007","journal-title":"J Infect Dis"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2009.04.074_bib12","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1586\/14760584.7.9.1435","article-title":"Innate sensors of influenza virus: clues to developing better intranasal vaccines","volume":"7","author":"Ichinohe","year":"2008","journal-title":"Expert Rev Vaccines"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2009.04.074_bib13","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.4049\/jimmunol.178.8.5200","article-title":"TLR3 is essential for the induction of protective immunity against Punta Toro Virus infection by the double-stranded RNA (dsRNA), poly (I:C12U), but not poly (I:C) differential recognition of synthetic dsRNA molecules","volume":"178","author":"Gowen","year":"2007","journal-title":"J Immunol"},{"issue":"October (12\u201313)","key":"10.1016\/j.vaccine.2009.04.074_bib14","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1016\/j.micinf.2006.07.018","article-title":"Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection","volume":"8","author":"Asahi-Ozaki","year":"2006","journal-title":"Microbes Infect\/Institut Pasteur"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09006409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09006409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T05:38:42Z","timestamp":1710653922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09006409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":14,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0264410X09006409"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.04.074","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}